| David Huffman, | |
|
7220 S Kipling Pl, Painesville, OH 44077-9531 | |
| (216) 408-4104 | |
| Not Available |
| Full Name | David Huffman |
|---|---|
| Gender | Male |
| Speciality | Nurse Practitioner |
| Experience | 9 Years |
| Location | 7220 S Kipling Pl, Painesville, Ohio |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457735243 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LA2100X | Nurse Practitioner - Acute Care | 253915 (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Uh Regional Hospitals | Richmond heights, OH | Hospital |
| University Hospitals Of Cleveland | Cleveland, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Primary Care Practices Inc | 3072417534 | 940 |
News Archive
The benefits of hormone therapy on atherosclerosis relates to achieved estradiol levels among those women who initiate HT early in postmenopause. Despite the use of hormones, however, women's estradiol levels are often inconsistent.
Lockton Companies, the world's largest private insurance broker, is offering insights on the impact of health reform through its newly formed Lockton Health Reform Advisory Practice. Lockton's new team provides employers with information, advice, and practical approaches as they respond to health reform legislation and understand impact on their employees and businesses.
A first-ever, long-term study of patients who underwent robot-assisted surgery to remove their cancerous prostates found that nearly 87 percent of them had no recurrence of the disease after five years.
Zalicus Inc., a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain and immuno-inflammatory diseases, today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental new drug application (sNDA) filed by Mallinckrodt Inc., a subsidiary of Covidien plc, for the 32 mg dose strength of EXALGO (hydromorphone HCl) Extended-Release Tablets (CII), for the management of moderate to severe pain in opioid-tolerant patients requiring continuous, around-the-clock opioid analgesia for an extended period of time.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
› Verified 1 days ago
| Entity Name | University Primary Care Practices Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003935339 PECOS PAC ID: 3072417534 Enrollment ID: O20031125000767 |
News Archive
The benefits of hormone therapy on atherosclerosis relates to achieved estradiol levels among those women who initiate HT early in postmenopause. Despite the use of hormones, however, women's estradiol levels are often inconsistent.
Lockton Companies, the world's largest private insurance broker, is offering insights on the impact of health reform through its newly formed Lockton Health Reform Advisory Practice. Lockton's new team provides employers with information, advice, and practical approaches as they respond to health reform legislation and understand impact on their employees and businesses.
A first-ever, long-term study of patients who underwent robot-assisted surgery to remove their cancerous prostates found that nearly 87 percent of them had no recurrence of the disease after five years.
Zalicus Inc., a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain and immuno-inflammatory diseases, today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental new drug application (sNDA) filed by Mallinckrodt Inc., a subsidiary of Covidien plc, for the 32 mg dose strength of EXALGO (hydromorphone HCl) Extended-Release Tablets (CII), for the management of moderate to severe pain in opioid-tolerant patients requiring continuous, around-the-clock opioid analgesia for an extended period of time.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
› Verified 1 days ago
| Entity Name | Community Intensivists, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992131742 PECOS PAC ID: 8426272923 Enrollment ID: O20140623001963 |
News Archive
The benefits of hormone therapy on atherosclerosis relates to achieved estradiol levels among those women who initiate HT early in postmenopause. Despite the use of hormones, however, women's estradiol levels are often inconsistent.
Lockton Companies, the world's largest private insurance broker, is offering insights on the impact of health reform through its newly formed Lockton Health Reform Advisory Practice. Lockton's new team provides employers with information, advice, and practical approaches as they respond to health reform legislation and understand impact on their employees and businesses.
A first-ever, long-term study of patients who underwent robot-assisted surgery to remove their cancerous prostates found that nearly 87 percent of them had no recurrence of the disease after five years.
Zalicus Inc., a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain and immuno-inflammatory diseases, today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental new drug application (sNDA) filed by Mallinckrodt Inc., a subsidiary of Covidien plc, for the 32 mg dose strength of EXALGO (hydromorphone HCl) Extended-Release Tablets (CII), for the management of moderate to severe pain in opioid-tolerant patients requiring continuous, around-the-clock opioid analgesia for an extended period of time.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| David Huffman, 7220 S Kipling Pl, Painesville, OH 44077-9531 Ph: (216) 408-4104 | David Huffman, 7220 S Kipling Pl, Painesville, OH 44077-9531 Ph: (216) 408-4104 |
News Archive
The benefits of hormone therapy on atherosclerosis relates to achieved estradiol levels among those women who initiate HT early in postmenopause. Despite the use of hormones, however, women's estradiol levels are often inconsistent.
Lockton Companies, the world's largest private insurance broker, is offering insights on the impact of health reform through its newly formed Lockton Health Reform Advisory Practice. Lockton's new team provides employers with information, advice, and practical approaches as they respond to health reform legislation and understand impact on their employees and businesses.
A first-ever, long-term study of patients who underwent robot-assisted surgery to remove their cancerous prostates found that nearly 87 percent of them had no recurrence of the disease after five years.
Zalicus Inc., a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain and immuno-inflammatory diseases, today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental new drug application (sNDA) filed by Mallinckrodt Inc., a subsidiary of Covidien plc, for the 32 mg dose strength of EXALGO (hydromorphone HCl) Extended-Release Tablets (CII), for the management of moderate to severe pain in opioid-tolerant patients requiring continuous, around-the-clock opioid analgesia for an extended period of time.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
› Verified 1 days ago
Donna Sheahan, CNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 236 Ardmore Blvd, Painesville, OH 44077 Phone: 440-289-3162 | |
Mrs. Nancy Rigden, NEONATAL NURSE PRACT Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 10 E Washington St, Painesville, OH 44077 Phone: 440-354-2400 | |
Ms. Margaret Ellen Henning, MSN, RN, NP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1506 Mentor Ave, Painesville, OH 44077 Phone: 866-389-2727 | |
Patricia Kelly, C.N.P. Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 7580 Auburn Rd, Suite 202, Painesville, OH 44077 Phone: 440-352-0400 Fax: 440-352-4535 | |
Trisha Laska, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1506 Mentor Ave, Painesville, OH 44077 Phone: 440-354-5609 | |
Ms. Georgia Zinsser Saltzman, CPNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 462 Chardon St, Painesville, OH 44077 Phone: 440-853-1501 |